Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.
Start price
08.03.23
/
50%
€19.83
Target price
08.03.24
€30.31
Performance (%)
7.94%
End price
09.03.24
€21.40
Summary
This prediction ended on 09.03.24 with a price of €21.40. The BUY prediction by Canaccord_Genuity_Gr finished with a performance of 7.94%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Corcept Therapeutics Inc. | 3.737% | 3.737% | 61.944% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $33.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
In the thread Trading Corcept Therapeutics Inc.
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten